ARTICLE | Clinical News
Eravacycline: Completed Phase III enrollment
August 11, 2014 7:00 AM UTC
Tetraphase completed enrollment of 536 patients with cIAI in the double-blind, double-dummy, international Phase III IGNITE 1 trial evaluating 1 mg/kg IV eravacycline every 12 hours vs. 1 g IV ertapen...